
AgeX Therapeutics
Biotechnology company focused on the emerging field of interventional gerontology.
Market cap
$27.8m
Enterprise value
$32m
Share price
$11.10 AGE
Authorizing premium user...
Biotechnology company focused on the emerging field of interventional gerontology.